GlassScriptPhysician profile
Larry A Suecof
NPI 1033104062
$599.92
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $25.16 · 2021: $96.22 · 2022: $122 · 2023: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $159.57 | 2021-2023 | Nuzyra |
| Kerecis Limited | $138.30 | 2019-2021 | |
| Bioventus LLC | $46.74 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $42.92 | 2021 | |
| Smith+Nephew, INC. | $39.22 | 2019-2023 | Grafix Pl |
| Next Science LLC | $36.10 | 2023 | Blastx, Xperience, Surgx |
| Stryker Corporation | $31.77 | 2019 | |
| Lifenet Health | $27.78 | 2023 | |
| Merck Sharp & Dohme LLC | $27.25 | 2019 | |
| Nevro Corp. | $18.78 | 2019 | |
| Organogenesis INC. | $16.40 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $15.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Suecof listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.